Grünwald V - Search Results

1

Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients.

Seidel C, Fenner M, Merseburger AS, Reuter C, Ivanyi P, Länger F, Ganser A, Grünwald V. Seidel C, et al. Among authors: grunwald v. World J Urol. 2011 Jun;29(3):355-60. doi: 10.1007/s00345-010-0642-3. Epub 2011 Jan 22. World J Urol. 2011. PMID: 21258806

2

Repeated administration of short infusions of bendamustine: a phase I study in patients with advanced progressive solid tumours.

Schöffski P, Hagedorn T, Grünwald V, Paul H, Merkle K, Kowalski R, Ganser A. Schöffski P, et al. Among authors: grunwald v. J Cancer Res Clin Oncol. 2000 Jan;126(1):41-7. doi: 10.1007/pl00008463. J Cancer Res Clin Oncol. 2000. PMID: 10641748 Clinical Trial.

3

Weekly administration of bendamustine: a phase I study in patients with advanced progressive solid tumours.

Schöffski P, Seeland G, Engel H, Grünwald V, Paul H, Merkle K, Kowalski R, Ganser A. Schöffski P, et al. Among authors: grunwald v. Ann Oncol. 2000 Jun;11(6):729-34. doi: 10.1023/a:1008309911008. Ann Oncol. 2000. PMID: 10942063 Free article. Clinical Trial.

4

Metastatic malignant ameloblastoma responding to chemotherapy with paclitaxel and carboplatin.

Grünwald V, Le Blanc S, Karstens JH, Weihkopf T, Kuske M, Ganser A, Schöffski P. Grünwald V, et al. Ann Oncol. 2001 Oct;12(10):1489-91. doi: 10.1023/a:1012522929861. Ann Oncol. 2001. PMID: 11762824 Free article.

5

Acral necrosis after inadequate excessive administration of bleomycin in a testicular cancer patient.

Grünwald V, Bolte O, Wiebe S, Ganser A, Schöffski P. Grünwald V, et al. Onkologie. 2005 Jan;28(1):41-3. doi: 10.1159/000082054. Onkologie. 2005. PMID: 15591723

6

Targeting vascular endothelial growth factor (VEGF)-receptor-signaling in renal cell carcinoma.

Reuter CW, Morgan MA, Grünwald V, Herrmann TR, Burchardt M, Ganser A. Reuter CW, et al. Among authors: grunwald v. World J Urol. 2007 Mar;25(1):59-72. doi: 10.1007/s00345-007-0152-0. Epub 2007 Mar 6. World J Urol. 2007. PMID: 17340158 Review.

7

Managing side effects of angiogenesis inhibitors in renal cell carcinoma.

Grünwald V, Heinzer H, Fiedler W. Grünwald V, et al. Onkologie. 2007 Oct;30(10):519-24. doi: 10.1159/000107721. Epub 2007 Sep 21. Onkologie. 2007. PMID: 17890892 Review.

8

Targeted therapies for patients with germ cell tumors.

Fenner MH, Beutel G, Grünwald V. Fenner MH, et al. Among authors: grunwald v. Expert Opin Investig Drugs. 2008 Apr;17(4):511-22. doi: 10.1517/13543784.17.4.511. Expert Opin Investig Drugs. 2008. PMID: 18363516 Review.

9

Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysis.

Johannsen M, Flörcken A, Bex A, Roigas J, Cosentino M, Ficarra V, Kloeters C, Rief M, Rogalla P, Miller K, Grünwald V. Johannsen M, et al. Among authors: grunwald v. Eur Urol. 2009 Jun;55(6):1430-8. doi: 10.1016/j.eururo.2008.10.021. Epub 2008 Oct 18. Eur Urol. 2009. PMID: 18950936

10

Molecular targeted therapies for solid tumors: management of side effects.

Grünwald V, Soltau J, Ivanyi P, Rentschler J, Reuter C, Drevs J. Grünwald V, et al. Onkologie. 2009 Mar;32(3):129-38. doi: 10.1159/000194949. Epub 2009 Feb 16. Onkologie. 2009. PMID: 19295254 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters